Multidrug resistance (MDR) is often related to expression of P-glycopr
otein (Pgp) or Multidrug Resistance Protein (MRP). Pgp-mediated MDR ca
n be evaluated by determining cellular retention of fluorescent substr
ates by now cytometry. This study determined if agents used to evaluat
e Pgp function also can be used to evaluate MRP function. Cellular ret
ention of doxorubicin (Dox), Rhodamine-123 (Rh-123), and 3,3'-diethylo
xacarbocyanine iodide (DiOC(2)(3)) were studied in MRP-expressing cell
lines (HL60/Adr and HT1080/DR4), whereas a Pgp expressing cell fine (
A2780/Dx5) served as a positive control. Overexpression of Pgp correla
ted inversely with retention of Dox, Rh-123, and DiOC(2)(3); however,
under identical experimental conditions (1 h reincubation in drug-free
medium), no retention difference of the three agents was detected bet
ween parental and MRP-expressing resistant cells. Upon extending the r
eincubation time to 4 h, an efflux of Rh-123 and Dox in the resistant
Lines became apparent and even more pronounced after 24 h; however, st
ill no efflux was detectable for DiOC(2)(3). Incubation of the cells w
ith a modulator of MDR, PAK-104P, negated the observed drug efflux in
Pgp and MRP expressing cells, which correlated with increased sensitiv
ity of the MDR Lines to doxorubicin. Thus both Dox and Rh-123 can be u
sed to evaluate MRP-function, but DiOC(2)(3) can not. (C) 1996 Wiley-L
iss, Inc.